NCT06935591 - Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study | Biotech Hunter

Enrollment

384

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions

Atrial Fibrillation (AF)

Interventions

PROCEDURE

Pulmonary Vein Isolation

Subjects will receive treatment for Atrial Fibrillation with Pulmonary Vein Isolation per standard of care.

DEVICE

vMap® + Pulmonary Vein Isolation

Subjects will receive treatment for Atrial Fibrillation with the use of the vMap® system and Pulmonary Vein Isolation.

Trial Locations (8)

RECRUITING

Westchester Medical Center, Valhalla

RECRUITING

Baptist Health Jacksonville, Jacksonville

NOT_YET_RECRUITING

USF Health, Tampa

RECRUITING

Baptist Health Lexignton, Lexington

NOT_YET_RECRUITING

OhioHealth, Columbus

NOT_YET_RECRUITING

Indiana University, Indianapolis

NOT_YET_RECRUITING

Penn Presbyterian, Philadelphia

NOT_YET_RECRUITING

Catharina Ziekenhuis, Eindhoven